newsfilter
← Latest News
PR Newswire·

ADC Therapeutics to Participate in March Investor Conferences

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced...